Author:
Jackson Michael John,Andree Terrance H.,Hansard Matthew,Hoffman Diane C.,Hurtt Mark R.,Kehne John H.,Pitler Thomas A.,Smith Lance A.,Stack Gary,Jenner Peter
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference29 articles.
1. Ahlskog JE, Muenter MD (2001) Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16:448–458
2. Akai T, Yamaguchi M, Mizuta E, Kuno S (1993) Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys. Ann Neurol 33:507–511
3. Akai T, Ozawa M, Yamaguchi M, Mizuta E, Kuno S (1995) Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys. J Pharmacol Exp Ther 273:309–314
4. Andree TH, Stack G, Rosenzweig-Lipson S, Coupet J (1999) WAY-135452: a potent novel D2/D3 partial agonist for the treatment of schizophrenia. In: 38th annual meeting of the American College of Neuropsychopharmacology
5. Baronti F, Mouradian MM, Conant KE, Giuffra M, Brughitta G, Chase TN (1992) Partial dopamine agonist therapy of levodopa-induced dyskinesias. Neurology 42:1241–1243
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献